Zevra Therapeutics (ZVRA) Research & Development (2016 - 2025)
Historic Research & Development for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to $3.4 million.
- Zevra Therapeutics' Research & Development fell 6864.32% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year decrease of 5909.35%. This contributed to the annual value of $42.1 million for FY2024, which is 575.04% up from last year.
- According to the latest figures from Q3 2025, Zevra Therapeutics' Research & Development is $3.4 million, which was down 6864.32% from $3.4 million recorded in Q2 2025.
- Zevra Therapeutics' Research & Development's 5-year high stood at $12.3 million during Q3 2023, with a 5-year trough of $2.2 million in Q3 2021.
- In the last 5 years, Zevra Therapeutics' Research & Development had a median value of $5.4 million in 2022 and averaged $6.4 million.
- Per our database at Business Quant, Zevra Therapeutics' Research & Development soared by 18082.41% in 2023 and then tumbled by 7346.26% in 2025.
- Zevra Therapeutics' Research & Development (Quarter) stood at $2.8 million in 2021, then soared by 132.86% to $6.5 million in 2022, then skyrocketed by 74.61% to $11.4 million in 2023, then fell by 26.87% to $8.4 million in 2024, then crashed by 58.91% to $3.4 million in 2025.
- Its Research & Development was $3.4 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.3 million in Q1 2025.